Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9045349rdf:typepubmed:Citationlld:pubmed
pubmed-article:9045349lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:9045349lifeskim:mentionsumls-concept:C0023449lld:lifeskim
pubmed-article:9045349lifeskim:mentionsumls-concept:C0149615lld:lifeskim
pubmed-article:9045349lifeskim:mentionsumls-concept:C0559189lld:lifeskim
pubmed-article:9045349lifeskim:mentionsumls-concept:C0544452lld:lifeskim
pubmed-article:9045349lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:9045349pubmed:issue2lld:pubmed
pubmed-article:9045349pubmed:dateCreated1997-3-6lld:pubmed
pubmed-article:9045349pubmed:abstractTextUsing the data from the GETMON ("Grupo Español de Trasplante de Medula Osea en Niños") we carried out a retrospective analysis of the results of allogeneic bone marrow transplantation (alloBMT) compared to autologous bone marrow transplantation (ABMT) in 113 paediatric patients with acute lymphoblastic leukaemia (ALL) in second remission. Transplants were performed by the following centers, from April 1983 to December 1991: H. Vall d'Hebrón and H. Sant Pau from Barcelona, H. Ramón y Cajal and H. Niño Jesús from Madrid and H. Marqués de Valdecilla from Santander.lld:pubmed
pubmed-article:9045349pubmed:languagespalld:pubmed
pubmed-article:9045349pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9045349pubmed:citationSubsetIMlld:pubmed
pubmed-article:9045349pubmed:statusMEDLINElld:pubmed
pubmed-article:9045349pubmed:monthAprlld:pubmed
pubmed-article:9045349pubmed:issn0036-4355lld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:BadeltAAlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:BanìKKlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:MuñozAAlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:OrtegaJ JJJlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:DíazM AMAlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:MaderoLLlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:CubellsJJlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:BurelJJlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:OlivéTTlld:pubmed
pubmed-article:9045349pubmed:authorpubmed-author:MaldonadoM...lld:pubmed
pubmed-article:9045349pubmed:issnTypePrintlld:pubmed
pubmed-article:9045349pubmed:volume41lld:pubmed
pubmed-article:9045349pubmed:ownerNLMlld:pubmed
pubmed-article:9045349pubmed:authorsCompleteYlld:pubmed
pubmed-article:9045349pubmed:pagination101-8lld:pubmed
pubmed-article:9045349pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:meshHeadingpubmed-meshheading:9045349-...lld:pubmed
pubmed-article:9045349pubmed:year1996lld:pubmed
pubmed-article:9045349pubmed:articleTitle[Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].lld:pubmed
pubmed-article:9045349pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9045349pubmed:publicationTypeEnglish Abstractlld:pubmed